Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-25
1996-03-12
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3816, A61K 3821
Patent
active
054985986
ABSTRACT:
An aqueous composition for spray nasal administration of a synthetic analog of vasopressin (desmopressin; actate containing between 2.5 and 7.5 .mu.g per 100 .mu.l. The composition may additionally contain an osmotic-pressure controlling agent, such as sodium chloride, a preservative, such as chlorobutanol or benzalkonium chloride, and a buffer stabilizing the pH between about 4 and 6. Buffers containing citrate and/or phosphate are preferred. Also disclosed is a sealed container filled with the composition, an assembly comprising the container and a spray pump, and the use of the composition, the container, and the assembly in the management of urinary disorders.
REFERENCES:
patent: 3794633 (1974-02-01), Kamber et al.
patent: 3929758 (1975-12-01), Hughes et al.
patent: 4033940 (1977-07-01), Hughes et al.
patent: 4093610 (1978-06-01), Abraham et al.
patent: 4216141 (1980-08-01), Rivier et al.
patent: 4271068 (1981-06-01), Kamber et al.
patent: 4351764 (1982-09-01), Birr
patent: 4487765 (1984-12-01), de Wied
patent: 4985242 (1991-01-01), Sekine et al.
patent: 5066716 (1991-11-01), Robey et al.
patent: 5124315 (1992-06-01), Ceschel et al.
Andersson et al., DDAVP: Pharmacology and Clinical Use, Drugs of Today, 1988, 24(7):509-528.
Vavra, Effect Of A Synthetic Analogue Of Vasopressin In Animals And In Patient With Diabetes Insipidue, Lancet, pp. 948-952 (1968).
Harris et al., J. of Pharm. Sci., vol. 77, No. 4, pp. 337-339 (1988).
Anik et al., J. of Pharm. Sci., vol. 73, No. 5, pp. 684-685 (1984).
Ferring AB
Peabody John
Richter Johann
LandOfFree
Composition for nasal administration of desmopressin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for nasal administration of desmopressin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for nasal administration of desmopressin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2099974